UK Drugs Policy

Debate between Caroline Lucas and Mike Thornton

Thursday 30th October 2014 Commons Chamber

[Caroline Lucas]

That is an extremely good point. I thank the hon. Gentleman for his very helpful intervention, which speaks for itself.

If we are to design a better drugs policy that is based on evidence, we need to agree on the objectives of drugs policy. For me, it is about protecting people, particularly the young and vulnerable, as well as reducing crime, improving health, promoting security and development, providing good value for money and protecting human rights. In setting out why that is important, I will say a little more about the impact of the current drugs policy and why I believe it adds to the case for a review; I will talk a little about the growing consensus on rethinking the current approach to drugs policy; and I will say a little about Brighton and Hove, where my constituency is situated, where the approach of following the evidence as far as possible has delivered benefits.

Before doing any of that, I would like to talk about Martha. Martha’s mother, Anne-Marie Cockburn, is in Parliament with us today. Like so many parents, she had always wanted to protect her child. However, on 20 July 2013, she learned that that was not always possible. On that day, Martha swallowed half a gram of MDMA powder—ecstasy—and died. She was 15 years old. Today, 30 October, would have been Martha’s 17th birthday. She is not celebrating that birthday because the Misuse of Drugs Act did not protect her. Making MDMA illegal did not protect Martha. We owe it to her and to Anne-Marie, and to the many other people who have died drug-related deaths and their families and loved ones, to ensure that in future each and every one of us is offered the best possible protection by our drugs laws.

In her incredibly moving blog, “What Martha Did Next”, Anne-Marie writes:

“Had Martha known that what she was about to take was 91% pure, she would probably have taken a lot less, in fact I’d go as far as to say that she might still be alive.”

Anne-Marie argues that, under prohibition, it is impossible fully to educate people such as Martha, because there is no way to tell what drugs contain. Prohibition has not stopped risk-taking, but it has made those risks much more dangerous. Anne-Marie suggests that we are failing to protect children such as Martha—that we are letting them down—and that, alongside deterring young people from taking drugs, we need a regulatory model that reduces the risk if drugs do get into the hands of young people such as Martha.

I agree with Anne-Marie. Perhaps many people in the Chamber will not. However, the fact that Martha is not celebrating her 17th birthday today is surely the first of many good reasons to carry out an impact assessment of our drugs laws. We urgently need to know whether prohibition is an obstacle to education about drugs, and whether our children would be better protected by alternatives, such as strict regulation. Despite all the accusations that are thrown at those who are in favour of drug policy reform, the bottom line is that it is not about being pro-drugs, but about saving lives. The only credible way to do that is to know whether our policies are up to the job.

That is especially important because there is powerful evidence that the so-called war on drugs is making things worse. Far from being neutral, in many instances the current model pushes users towards more harmful products, behaviours and environments. Let me give two examples of what I mean. In doing so, it is crucial to distinguish between the suffering that is caused by drugs and that which is caused by drugs policy.

First, the vast majority of drug-related offending happens not because people take drugs, but because of drugs policy. Users are driven to burglary and theft to buy drugs at vastly inflated prices in an unregulated market. There is enormous potential significantly to reduce such crime and its impact on our communities under a different system.

Secondly, on legal highs, according to research into synthetic drugs by Demos and the UK Drug Policy Commission, 40 new substances emerged on to the market in 2010, compared with 24 in the previous year. By 2014, the figure had grown to 80 different synthetic drugs. Professor Les Iversen, the chairman of the Advisory Council on the Misuse of Drugs, recently admitted that drug control legislation is being forced to play “cat and mouse”. Such substances are routinely banned under the Misuse of Drugs Act, but that simply spawns more substances that, in turn, are banned. The legal process cannot keep up.

The Government have published a report today that recommends that all novel synthetic psychoactive substances, or legal highs as they are more widely known, be banned. I appreciate what they are trying to do with that policy, but I think that it is misguided. It fails to appreciate that many legal highs are the products of prohibition. Synthetic cannabis, for example, would not exist if there were a legally regulated supply of real cannabis. Nor does the policy recognise our knowledge that prohibition—in other words, banning things—does not stop people taking drugs, but simply increases the risks.

[Mike Thornton (Eastleigh) (LD)]

Does the hon. Lady agree that the only people the current policy really benefits are the drug lords and crime lords who sell this disgusting stuff to our children? If her policies were realised, it would put those people out of business for good.

[Caroline Lucas]

The hon. Gentleman is absolutely right that the current—